TITLE:
This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

CONDITION:
Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

INTERVENTION:
ZD6474

SUMMARY:

      The purpose of this study is to assess the efficacy and safety of ZD6474 in patients with
      NSCLC after Failure of Prior Platinum-based Chemotherapy.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Histologic or cytologic confirmation of NSCLC (locally advanced or metastatic, IB-IV)

          -  Failure of first-line platinum-based chemotherapy

        Exclusion Criteria:

          -  Mixed small cell or non-small-cell histology

          -  Bronchoalveolar carcinoma

          -  Prior chemotherapy or herbal preparations must be discontinued more than 4 weeks
             before the start of study therapy (6 weeks for nitrosoureas, mitomycin and suramin)

          -  Prior treatment with docetaxel
      
